Navigation Links
Early Diagnosis, Prompt Treatment Offer Hope for Those With Rare Form of Pulmonary Hypertension Called CTEPH
Date:11/9/2019

As part of Pulmonary Hypertension Awareness Month, on Nov. 13, the Pulmonary Hypertension Association (PHA) sets aside a day to help raise awareness and improve diagnosis of a rare form of pulmonary hypertension (PH) known as chronic thromboembolic pulmonary hypertension (CTEPH). Unlike some forms of PH, CTEPH has several treatment options, including a potentially curative surgery.

CTEPH is a form of pulmonary hypertension caused by old blood clots in the lungs. Some patients with CTEPH also have other changes in their pulmonary arteries that can make them narrower and stiffer. CTEPH stops or slows blood from flowing through the arteries and causes the right side of the heart to pump much harder, which can lead to right-heart failure and death. Symptoms include shortness of breath, fatigue and chest pain. Because these symptoms are similar to other common illnesses such as asthma, people can go months and years without a proper diagnosis.

To accurately diagnose CTEPH, doctors must incorporate a number of tests, including a right heart catheterization to measure blood pressure in the heart and lungs and a ventilation-perfusion (V/Q) scan that highlights how blood circulates through the lungs in order to locate blockages. Although CTEPH is a serious condition, the good news is that advances in treatment offer surgical and treatment options. One of these is a surgery that removes the chronic blood clots from the lungs.

“If left untreated, CTEPH is a deadly condition. Fortunately, it is perhaps the most treatable form of pulmonary hypertension where even a cure is oftentimes possible,” says Gustavo Heresi, M.D., a pulmonologist at Cleveland Clinic.

PHA will host a Facebook Live event at http://www.Facebook.com/PulmonaryHypertensionAssociation on CTEPH Awareness Day:

CTEPH Awareness Day will also feature inspiring stories by individuals with CTEPH through PHA’s “PHaces of Hope” campaign, which involves a community of individuals with PH, caregivers and health care professionals who share what gives them hope while facing this disease.

For resources on CTEPH Awareness Day, visit PHAssociation.org/CTEPHDay. The day’s activities can also be followed on social media using #CTEPHDay.

PHA’s CTEPH Awareness Day campaign is supported by a sponsorship from Bayer.

About the Pulmonary Hypertension Association

Headquartered in Silver Spring, Md., the Pulmonary Hypertension Association (PHA) is the country’s oldest and largest nonprofit patient association dedicated to the pulmonary hypertension (PH) community. Pulmonary hypertension is a rare, chronic and life-threatening disease of the lungs for which no cure currently exists. PHA’s mission is to extend and improve the lives of those affected by PH. To achieve this mission, PHA engages people with PH and their families, caregivers, health care providers, and researchers worldwide who work together to advocate for the PH community, provide support to patients, caregivers and families, offer up-to-date education and information on PH, improve quality patient care, and fund and promote research. For more information, visit http://www.PHAssociation.org and connect with PHA on Twitter, Instagram and Facebook.

Read the full story at https://www.prweb.com/releases/early_diagnosis_prompt_treatment_offer_hope_for_those_with_rare_form_of_pulmonary_hypertension_called_cteph/prweb16709935.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Clinical Team Researching the Impact of the EarlySense System Wins Best Novel Idea Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference
2. Health Diagnostic Laboratory, Inc. Announces Diabetes Prevention & Management Panel for Early Detection and Treatment of Disease
3. Preclinical and Phase 1 Data of VTX-2337 Presented at 2013 ASCO Annual Meeting Shows Early Activity in Ovarian Cancer
4. Rising Drug Resistance is Driving Early-Line Use of Powerful Antibiotics Such as Carbapenems for Gram-Negative Infections, According to Surveyed EU5 Physicians
5. From Autism to Diabetes to Parkinsons Disease: Pew Funds 22 Early-Career Scientists to Take Calculated Risks
6. New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development
7. CVS Caremark in Partnership with Ocean Conservancy Cleans Up Nearly 25,000 Pounds of Trash from Shorelines across the Country
8. Early Morning Insight: Baxter, CareFusion, Unilife, and Mindray Medical
9. Genalyte And Barbara Davis Diabetes Center Collaborate To Advance Multiplexed Antigen Panel For Early Diagnosis Of Type 1 Diabetes
10. Roche/Chugais Bitopertin Will Garner Nearly $1.5 Billion in Major-Market Sales in 2022 as the First Approved Treatment for Negative Symptoms in Schizophrenia
11. Differences Over Pathways Developed by Oncologists and MCOs May Create Conflict Over Prescribing Decisions in Early-Line Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2019)... ... December 02, 2019 , ... TopConsumerReviews.com recently awarded ... Remedies aimed at supporting Women’s Fertility and healthy natural ovulation. , Millions of ... some women than for others. Factors like weight, medical conditions, age, and even ...
(Date:11/30/2019)... PUNTA GORDA, Fla. (PRWEB) , ... November 29, 2019 , ... ... fleet expansion. This long awaited expansion was due to Amazon’s incredibly large purchase ... expansion had been delayed by Mercedes, they’ve recently received word on vehicle availability ...
(Date:11/27/2019)... ... November 27, 2019 , ... Home sales continue to be very robust at Wickenburg ... month, with the sale of Homesite 266 to Jim and Sue. Jim is a native ... years and are excited to start their next chapter at Wickenburg Ranch away from the ...
Breaking Medicine Technology:
(Date:12/4/2019)... (PRWEB) , ... December 04, 2019 , ... ... I study of AZD4041 for treating tobacco use and dependence. The study will ... central nervous system (CNS) penetrant antagonist of orexin-1 (hypocretin-1) receptors that is being ...
(Date:12/2/2019)... CITY, N.J. (PRWEB) , ... December 02, 2019 ... ... and disclosure compliance solutions, has worked with EMD Serono, the North American branch ... website, https://clinicaltrials.emdgroup.com . This site is designed to educate and inform patients, ...
(Date:12/2/2019)... GRAND RAPIDS, Mich. (PRWEB) , ... December 02, ... ... process – bringing unsurpassed efficiency and flexibility to the Sterile Processing Department. The ... is easy to clean. The P1000 has downward sliding doors that allow for ...
(Date:11/30/2019)... (PRWEB) , ... November 28, 2019 , ... ... company known for its award-winning cannabis cultivation, production and dispensary operations, has received ... Chocolates™ line of products. , “This is a great accomplishment for our company ...
(Date:11/30/2019)... ... , ... As Cumberland students enter the festive holiday season ... for academic backslide but rather opportunities for social-emotional growth. Teachers and counselors realize ... often during the break but might be faced with challenges surrounding the busyness ...
Breaking Medicine News(10 mins):